Delivery Order SPE2DB20D2104-SPE2DB25FMZCS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,496.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a commonly prescribed medication for diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $5,162.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order valued at $7,191.99 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used to treat type 2 diabetes in military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $39,850.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $7,793.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a delivery order valued at $8,482.69 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,929.01 by the Defense Logistics Agency on August 25, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This is a firm fixed-price delivery order with no set-aside designation, completed on August 26, 2025, representing a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZCSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,440.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 28, 2025, with completion scheduled for August 29, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used by military personnel and veterans through the Defense Health Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical supplier of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/28/25 |